nous airways but not with airway wall dimensions of membranous
airways (13).
The place of transbronchial biopsies in therapeutic trials
should at least be discussed (14). In severe asthma, it is difficult
to discriminate the contribution of the natural history of the
disease and its severity from the effects of current treatments,
and this probably explains many of the discrepancies among the
clinical trials conducted so far